NewswireTODAY - /newswire/ - Beijing, China, 2010/11/08 - ResearchInChina announces the release of a new report - China Diagnostic Reagent Industry Report, 2010.

In 2009, China’s diagnostic reagent market represented about 5% of the global market, and Chinese enterprises still concentrated on low-end biochemistry diagnostic reagent market.

In China, there had been more than 70 biochemistry diagnostic reagent producers by the end of 2009, with sales over RMB 4 billion in total. At present, there are only about a dozen of immune diagnostic reagent producers with sales of RMB 1.5 billion in total, and there are no more than five nucleic acid diagnostic reagent producers with the market size of no more than RMB 500 million in all. By contrast, in foreign markets, the share of biochemistry diagnostic reagent has become very low, while immune diagnostic reagent and nucleic acid diagnostic reagent featuring higher detection sensitivity and specificity have become the mainstream.

The major diagnostic reagent producers in China include KHB and Da An Gene, all of which hold certain market shares by virtue of their own technology strength. Da An Gene mainly produces nucleic acid diagnostic reagent which can compete with the international advanced level in technology and quality. In 2009, Da An Gene’s nucleic acid diagnostic reagent business accounted for over 50% of the company’s operating income and about 60% of the domestic nucleic acid diagnostic reagent market. In addition, with the launch of China nucleic acid blood screening market, the nucleic acid blood screening business is expected to become a new profit point of Da An Gene.

1. Industry Profile
1.1 Definition and Classification
1.2 Industrial Chain
1.2.1Upstream Market
1.2.2 Downstream Market

2. Operating Environment in China
2.1 Global Market
2.1.1 Development of Biopharmaceutical Industry Worldwide
2.1.2 Development of Diagnostic Reagent Industry Worldwide
2.2 Chinese Market
2.2.1 Development of Biopharmaceutical Industry in China
2.2.2 Relevant Policies of China

3. Development in China
3.1 Overview
3.2 Import & Export
3.3 Market Segments
3.3.1 Biochemistry Diagnostic Reagent
3.3.2 Immune Diagnostic Reagent
3.3.3 Nucleic Acid Diagnostic Reagent
3.4 Development Tendency of Diagnostic Reagent Sector in China

4. Domestic Major Producers
4.1 KHB
4.1.1 Profile
4.1.2 Operation
4.1.3 Operation of Diagnostic Reagent Business
4.2 Da An Gene
4.2.1 Profile
4.2.2 Operation
4.2.3 Operation of Diagnostic Reagent Business
4.3 Fosun Pharmaceutical (Group)
4.3.1 Profile
4.3.2 Operation
4.4 Biosino Bio-Technology & Science Inc
4.4.1 Profile
4.4.2 Operation
4.5 Zhuhai Livzon Diagnostics
4.5.1 Profile
4.5.2 Operation
4.6 ACON Laboratories
4.6.1 Profile
4.6.2 Operation
4.7 Beijing Wantai Biological Pharmacy
4.7.1 Profile
4.7.2 Operation
4.8 Shanghai Rongsheng Biotech
4.8.1 Profile
4.8.2 Operation
4.9 Beijing Chemclin Biotech
4.9.1 Profile
4.9.2 Operation
4.10 PG Biotech
4.10.1 Profile
4.10.2 Major Products
4.11 Kinghawk Pharmaceutical
4.11.1 Profile
4.11.2 Operation
4.12 ABON Biopharm (Hangzhou)
4.12.1 Profile
4.12.2 Operation
4.13 Shanghai Upper Bio-Tech Pharma
4.13.1 Profile
4.13.2 Operation
4.14 Beijing Leadman Biochemical
4.14.1 Profile
4.14.2 Operation
4.15 Blue Cross Bio-Medical (Beijing)
4.15.1 Profile
4.15.2 Operation
4.16 Inverness Medical (Shanghai)
4.16.1 Profile
4.16.2 Operation
4.17 Baso Diagnostics
4.17.1 Profile
4.17.2 Operation
4.18 Beijing North Institute of Biological Technology
4.18.1 Profile
4.18.2 Operation
4.19 DiaSys Diagnostic Systems (Shanghai)
4.19.1 Profile
4.19.2 Operation
4.20 Other Enterprises
4.20.1 Autobio
4.20.2 Biobase
4.20.3 Boson Biotechnology.

Agency / Source: ResearchInChina

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick NewswireToday Visibility Checker

Distribution / Indexing: [+]